Risk Factors That Influence Surgical Decision-Making for Patients with Low-Risk Differentiated Thyroid Cancer with Tumor Diameters of 1-4 cm

被引:22
|
作者
Wang, Xiangming [1 ]
Zhang, Chao [1 ]
Srivastava, Akanksha [2 ]
Yu, Wenbin [3 ]
Liu, Chuan [4 ]
Wei, Dongmin [5 ]
Li, Yuncheng [6 ]
Yang, Jianming [1 ]
机构
[1] Anhui Med Univ, Hosp 2, Dept Otolaryngol Head & Neck Surg, Hefei 230601, Peoples R China
[2] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[3] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Head & Neck Surg,Minist Educ Beijing, Beijing, Peoples R China
[4] Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Chongqing, Peoples R China
[5] Shandong Univ, Qilu Hosp, Dept Otorhinolaryngol, Jinan, Shandong, Peoples R China
[6] Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China
来源
CANCER MANAGEMENT AND RESEARCH | 2020年 / 12卷
关键词
differentiated thyroid cancer; cancer metastasis; operation type; factor analysis; LYMPH-NODE METASTASIS; CARCINOMA; SURGERY; RECURRENCE;
D O I
10.2147/CMAR.S268716
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There are several controversies between thyroid lobectomy and total thyroidectomy for surgical management of low-risk differentiated thyroid cancer (DTC) with a tumor diameter of 1-4 cm. Patients and Methods: In this study, we explore the factors related to selection of type of surgical procedure for 103 low-risk DTC patients with a tumor diameter of 1-4 cm. Results: Among 103 low-risk DTC patients with tumor diameters of 1-4 cm, 43 patients underwent total thyroidectomy and 60 patients underwent thyroid lobectomy based on postoperative pathology. A ROC curve showed that the optimal diagnostic threshold for selecting surgical modality was a tumor diameter of 2.15 cm. For these low-risk DTC patients, the sensitivity and specificity for predicting thyroid lobectomy when tumor diameter <2.15 cm while total thyroidectomy when tumor diameter >= 2.15 cm are 46.5% and 78.3%, respectively. There were significant differences between the selection of type of surgical procedure in patient groups with 1) tumors with multiple foci group vs a single focus (P<0.05), and 2) tumor diameter of >= 2.15 cm vs <2.15 cm (P 0.05). There was no significant difference between gender and age groups (P 0.05). Multivariate analysis confirmed that tumors with multiple foci and diameter >= 2.15 cm were the primary risk factors for implementation of total thyroidectomy (P<0.05). Conclusion: The diameter and multifocal nature of low-risk DTC tumors are the primary factors related to preferred surgical modality. This study revealed that thyroid lobectomy is more applicable to patients with tumor diameter <2.15 cm and a single focus, whereas, total thyroidectomy was preferred in patients with tumor diameter >= 2.15 cm and/or multiple foci.
引用
收藏
页码:12423 / 12428
页数:6
相关论文
共 50 条
  • [41] Risk factors for tumor enlargement in low-risk papillary thyroid microcarcinoma patients: a systematic review and meta-analysis
    Luo, Nengwen
    Shi, Xinlong
    Xia, Yu
    Gao, Luying
    Li, Xiaoyi
    Jiang, Yuxin
    ENDOCRINE, 2024, 85 (03) : 1041 - 1049
  • [42] Factors That Inform Individual Decision Making Between Active Surveillance, Hemithyroidectomy and Total Thyroidectomy for Low-Risk Thyroid Cancer: A Scoping Review
    Wei, Jessica
    Thwin, May
    Nickel, Brooke
    Glover, Anthony
    THYROID, 2022, 32 (07) : 807 - 818
  • [43] Factors Potential Patients Deem Important for Decision-Making in High-Risk Surgical Scenarios
    Dellen, Matthew
    Flanagan, Mindy
    Pfafman, Rachel
    Drouin, Michelle
    Pater, Jessica
    Pei, Kevin Y.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 236 (01) : 93 - 98
  • [44] Factors Potential Patients Deem Important for Decision-Making in High-Risk Surgical Scenarios
    Dellen, Matthew
    Flanagan, Mindy
    Pfafman, Rachel
    Drouin, Michelle
    Toscos, Tammy
    Pater, Jessica
    Pei, Kevin
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 235 (05) : S104 - S105
  • [45] The clinical impact of a new highly sensitive thyroglobulin assay in low-risk patients treated for differentiated thyroid cancer
    Iervasi, G.
    Iervasi, A.
    Carpi, A.
    Zucchelli, G. C.
    BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (08) : 494 - 494
  • [46] Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone
    Matrone, Antonio
    Faranda, Alessio
    Torregrossa, Liborio
    Gambale, Carla
    Minaldi, Elisa
    Prete, Alessandro
    De Napoli, Luigi
    Rossi, Leonardo
    Agate, Laura
    Cappagli, Virginia
    Puleo, Luciana
    Molinaro, Eleonora
    Materazzi, Gabriele
    Elisei, Rossella
    CURRENT ONCOLOGY, 2024, 31 (09) : 5528 - 5536
  • [47] Thyroglobulin levels after recombinant TSH in the follow-up of low-risk patients with differentiated thyroid cancer
    Vlassopoulou, V
    Vassilatou, E
    Botoula, E
    Gripeou, C
    Christoforaki, M
    Tzavara, I
    Thalassinos, N
    PROCEEDINGS OF THE 12TH INTERNATIONAL CONGRESS OF ENDOCRINOLOGY, 2004, : 1087 - 1090
  • [48] The Diagnostic Value of Stimulated Serum Thyroglobulin in the Follow-up of Low-Risk Patients with Differentiated Thyroid Cancer
    Wagenhofer, V.
    Mihaljevic, I.
    Kralj, T.
    Snajder, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S563 - S564
  • [49] Does remnants from low-risk differentiated thyroid cancer patients really be not treated with Iodine-131?
    Barbato, F.
    Capacchione, D.
    Nappi, A.
    Telesca, D.
    Tempone, A.
    Casolino, E.
    Nardelli, A.
    Castaldi, E.
    Ortosecco, G.
    Storto, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S321 - S321
  • [50] Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders' views on a low-risk breast screening pathway
    McWilliams, Lorna
    Woof, Victoria G.
    Donnelly, Louise S.
    Howell, Anthony
    Evans, D. Gareth
    French, David P.
    BMC CANCER, 2020, 20 (01)